• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Legend Biotech Corp ADR (NQ: LEGN )

    45.02 +0.75 (+1.69%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Oct 31, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Legend Biotech Corp ADR

    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Analyst's Verdict on Legend Biotech: Doubts On Commercial Execution, Long- Term Market Share
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 25, 2023
    Via Benzinga
    Legend Biotech Announces Submission to the European Medicines Agency for Expanded Use of CARVYKTI® (ciltacabtagene autoleucel)
    From Legend Biotech Corporation
    Via Business Wire
    The Latest Analyst Ratings for Legend Biotech
    Via Benzinga
    Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
    Via Benzinga
    Legend Biotech Reports First Quarter 2023 Results and Recent Highlights
    From Legend Biotech Corporation
    Via Business Wire
    Legend Biotech to Demonstrate Progress in Advancing Potential Treatment Options for Patients with Multiple Myeloma at ASCO and EHA Annual Meetings
    From Legend Biotech Corporation
    Via Business Wire
    Legend Biotech Announces Participation in Upcoming Investor Conference
    From Legend Biotech Corporation
    Via Business Wire
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    Legend Biotech Corporation Announces Pricing of Registered Direct Offering of $350 Million of American Depositary Shares
    From Legend Biotech Corporation
    Via Business Wire
    Johnson & Johnson Ignites CAR-T Ambitions With Licensing Pact With Cellular Biomedicine
    Johnson & Johnson's (NYSE: JNJ) pharma unit Janssen  
    Via Benzinga
    After Jumping 49% in 1 Month, Is It Too Late to Buy Legend Biotech?
    Legend's cell therapy seems like it's a winner, but it might be priced in already. 
    Via The Motley Fool
    Potential Breakout Setups To Watch On Wednesday
    The U.S. stock market has weakened throughout Tuesday’s trading session and the major indices were sitting near session lows heading into the closing bell. 
    Via Benzinga
    Why Legend Biotech Stock Is Having Its Best Month Yet
    With the biotech market’s focus back on treatments for cancer and other life-threatening diseases, Legend has now tripled off its bottom to a record high. 
    Via MarketBeat
    Legend Bio Hits Profit-Taking Zone After Reportedly Confirming Key Study Results
    Legend Bio is on a run on excitement for its multiple myeloma treatment. 
    Via Investor's Business Daily
    Why Shares of Geron Are Up 30% This Week
    The company's CEO was scheduled to speak at a virtual conference on Thursday. 
    Via The Motley Fool
    Where Is The Current Bull Market? Scan Of Stocks Gaining Over 20% Over The Past Week Almost Exclusively Yields Biotech Names
    Where is the current bull market? All indications would be that it's in biotech! The broader market is not really moving. There have been plenty of attention-grabbing headlines, and earnings season is... 
    Via Benzinga
    7 Biotech Stocks That Could Cure Your Portfolio Woes
    If you want to revitalize your portfolio with some exciting opportunities, these biotech stocks to buy might fit the bill. 
    Via InvestorPlace
    10 Health Care Stocks With Whale Alerts In Today's Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Travelers Companies Shares Are Trading Higher By Over 5%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Gainers China Jo-Jo Drugstores, Inc. (NASDAQ: CJJD) gained 85.2% to $1.25 after the company announced the termination of its previously proposed registered direct offering. 
    Via Benzinga
    Why Shares of Legend Biotech Jumped Wednesday
    A leaked abstract on a phase 3 trial for the company's multiple myeloma drug Carvykti gave the stock a jolt. 
    Via The Motley Fool
    Legend Biotech Corp. (NASDAQ: LEGN) Leading the Way in Wednesday Trading Based on Percentage Gain
    Via Investor Brand Network
    Legend Biotech Breaks Out After Leaked Documents Show Big CAR-T Benefit
    The company could have the best-in-class CAR-T drug for multiple myeloma patients. 
    Via Investor's Business Daily
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Western Alliance Bancorporation, Intuitive Surgical And Other Big Stocks Moving Higher In Wednesday's Pre-Market Session
    U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session. Western Alliance Bancorporation (NYSE: WAL) shares jumped 15.4% to $37.50... 
    Via Benzinga
    Legend Biotech Announces Appointment of Chief Medical Officer
    From Legend Biotech
    Via Business Wire
    10 Health Care Stocks Whale Activity In Today's Session
    Via Benzinga
    Legend Biotech Establishes Strategic Advisory Board
    From Legend Biotech
    Via Business Wire
    Legend Biotech Reports Full-Year 2022 Results and Recent Highlights
    From Legend Biotech
    Via Business Wire
    < Previous 1 2 3 4 5 6 7 8 9 Next >
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.